• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医生专业的丁丙诺啡处方趋势。

Trends In Buprenorphine Prescribing By Physician Specialty.

机构信息

Hefei Wen (

Tyrone F. Borders is a professor of health management and policy and the Foundation for a Healthy Kentucky Endowed Chair in Rural Health Policy, both at the University of Kentucky.

出版信息

Health Aff (Millwood). 2019 Jan;38(1):24-28. doi: 10.1377/hlthaff.2018.05145.

DOI:10.1377/hlthaff.2018.05145
PMID:30615523
Abstract

Office-based visits involving a buprenorphine prescription increased significantly among primary care and specialist physicians from 2006 to 2014. The growing involvement of nonpsychiatry physicians in buprenorphine prescribing has the potential to provide better access to care for people with opioid use disorders.

摘要

从 2006 年到 2014 年,初级保健医生和专科医生开出的丁丙诺啡处方的门诊就诊量显著增加。越来越多的非精神科医生参与丁丙诺啡的处方开具,这有可能为患有阿片类药物使用障碍的人提供更好的治疗机会。

相似文献

1
Trends In Buprenorphine Prescribing By Physician Specialty.医生专业的丁丙诺啡处方趋势。
Health Aff (Millwood). 2019 Jan;38(1):24-28. doi: 10.1377/hlthaff.2018.05145.
2
Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine.重新思考阿片类药物剂量递减、处方阿片类药物依赖以及丁丙诺啡的适应症
Ann Intern Med. 2019 Sep 17;171(6):427-429. doi: 10.7326/M19-1488. Epub 2019 Aug 27.
3
Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?在医疗实践中开具丁丙诺啡治疗阿片类药物使用障碍:基于诊室的门诊治疗能否解决美国的阿片类药物危机?
Addiction. 2019 Nov;114(11):1992-1999. doi: 10.1111/add.14733. Epub 2019 Jul 25.
4
Characteristics of Office-Based Buprenorphine Prescribers for Medicare Patients.基层医疗机构开处丁丙诺啡处方的医生特点。
J Am Board Fam Med. 2020 Jan-Feb;33(1):9-16. doi: 10.3122/jabfm.2020.01.190233.
5
Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.家庭医生采用丁丙诺啡维持疗法的障碍分析。
Rural Remote Health. 2015;15:3019. Epub 2015 Feb 4.
6
Early-Career and Graduating Physicians More Likely to Prescribe Buprenorphine.早期职业医生和即将毕业的医生更有可能开丁丙诺啡处方。
J Am Board Fam Med. 2020 Jan-Feb;33(1):7-8. doi: 10.3122/jabfm.2020.01.190230.
7
Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US.美国美沙酮处方医生对患者的关注程度。
JAMA. 2021 Jun 1;325(21):2206-2208. doi: 10.1001/jama.2021.4469.
8
Steps physicians report taking to reduce diversion of buprenorphine.医生报告采取的减少丁丙诺啡转用的步骤。
Am J Addict. 2013 May-Jun;22(3):184-7. doi: 10.1111/j.1521-0391.2012.00335.x.
9
Changes in Buprenorphine Prescribing in Community Health Centers.社区卫生中心丁丙诺啡处方的变化
JAMA Health Forum. 2024 Apr 5;5(4):e240634. doi: 10.1001/jamahealthforum.2024.0634.
10
Geographic and specialty distribution of US physicians trained to treat opioid use disorder.接受过治疗阿片类药物使用障碍培训的美国医生的地理分布和专业分布。
Ann Fam Med. 2015 Jan-Feb;13(1):23-6. doi: 10.1370/afm.1735.

引用本文的文献

1
Filling the Treatment Gap: Geographic Expansion of Buprenorphine Providers Across the U.S.填补治疗缺口:丁丙诺啡提供者在美国的地域扩张
AJPM Focus. 2024 Oct 16;4(1):100284. doi: 10.1016/j.focus.2024.100284. eCollection 2025 Feb.
2
Organization of primary care and early MOUD discontinuation.初级保健组织与早期药物辅助治疗停药
Addict Sci Clin Pract. 2024 Dec 19;19(1):96. doi: 10.1186/s13722-024-00527-w.
3
Clinician Prescribing Practices Involving Medications for Alcohol Use Disorder.临床医生针对酒精使用障碍开具药物的处方行为。
Am J Prev Med. 2025 Mar;68(3):446-454. doi: 10.1016/j.amepre.2024.11.006. Epub 2024 Nov 28.
4
Increasing medication assisted treatment in rural primary care practice: a qualitative comparative analysis from IT MATTTRs Colorado.在农村基层医疗实践中增加药物辅助治疗:来自科罗拉多州IT MATTTRs的定性比较分析。
Front Med (Lausanne). 2024 Oct 2;11:1450672. doi: 10.3389/fmed.2024.1450672. eCollection 2024.
5
State-level racial and ethnic disparities in buprenorphine treatment duration in the United States.美国州级丁丙诺啡治疗时长方面的种族和族裔差异
Am J Addict. 2025 Jan;34(1):69-74. doi: 10.1111/ajad.13638. Epub 2024 Aug 6.
6
Optimizing Patient Engagement in Treatment for Opioid Use Disorder: Primary Care Team Perspectives on Influencing Factors.优化阿片类物质使用障碍治疗中的患者参与度:基层医疗团队对影响因素的看法
J Gen Intern Med. 2024 Dec;39(16):3196-3204. doi: 10.1007/s11606-024-08963-9. Epub 2024 Jul 29.
7
No Time to Wait: Leveraging Primary Care to Treat Stimulant Use Disorder.刻不容缓:利用初级保健治疗兴奋剂使用障碍
Am J Prev Med. 2024 Sep;67(3):464-469. doi: 10.1016/j.amepre.2024.05.005. Epub 2024 May 17.
8
Primary Care Providers' Experiences Treating Opioid Use Disorder Using Telehealth in the Height of the COVID-19 Pandemic.初级保健提供者在 COVID-19 大流行期间使用远程医疗治疗阿片类药物使用障碍的经验。
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241246359. doi: 10.1177/21501319241246359.
9
How Does Telehealth Expansion Change Access to Healthcare for Patients With Different Types of Substance Use Disorders?远程医疗的扩展如何改变不同类型物质使用障碍患者获得医疗保健的机会?
Subst Use Addctn J. 2024 Jul;45(3):473-485. doi: 10.1177/29767342241236028. Epub 2024 Mar 17.
10
Surgeons' knowledge regarding perioperative pain management in patients with opioid use disorder: a survey among 260 members of the American College of Surgeons.外科医生对阿片类药物使用障碍患者围手术期疼痛管理的认识:对美国外科医师学会260名成员的调查。
Patient Saf Surg. 2024 Mar 4;18(1):9. doi: 10.1186/s13037-024-00392-1.